| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Fraser Laboratories (J.L.R., R.M., U.K., Y.C.P.), Departments of Medicine, Pharmacology and Therapeutics, Neurology and Neurosurgery, McGill University and Royal Victoria Hospital, Montréal, Québec, Canada, H3A 1A1; and The Vollum Institute (V.O.C., M.R., M.J.L.), Oregon Health & Science University, Portland, Oregon 97201
Address all correspondence and requests for reprints to: Dr. Y. C. Patel, Room M3-15, Royal Victoria Hospital, 687 Pine Avenue West, Montréal, Québec H3A 1A1, Canada. E-mail: yogesh.patel{at}mcgill.ca.
The peptide somatostatin (SST) is widely synthesized in the brain and periphery and acts through a family of five receptors (SSTR1-5) to exert numerous effects. A gene product related to SST, cortistatin (CST), also interacts with SSTR1-5. Here we have investigated the regulation of SSTR1-5 and of CST in SST knockout (SSTKO) mice. The five SSTRs were quantitated individually by subtype-selective binding analysis, by immunocytochemistry, and by mRNA measurement and showed, in the brain of SSTKO mice, up-regulation of subtypes 1, 2, 4, and 5, and down-regulation of SSTR3. Peripheral tissues displayed both subtype- and tissue-specific changes in SSTR1-5 mRNA levels of expression. Lack of SST did not up-regulate normal CST expression in brain nor did it induce its expression in the periphery. SST-like immunoreactivity, however, was induced in the proximal midgut in SSTKO animals, suggesting intestinal expression of a novel SST-like gene.
This article has been cited by other articles:
 |
|
 |
|
  A. Ben-Shlomo, C. Zhou, O. Pichurin, V. Chesnokova, N.-A. Liu, M. D. Culler, and S. Melmed Constitutive Somatostatin Receptor Activity Determines Tonic Pituitary Cell Response Mol. Endocrinol., March 1, 2009; 23(3): 337 - 348. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. Qiu, T. Zeyda, B. Johnson, U. Hochgeschwender, L. de Lecea, and M. K. Tallent Somatostatin Receptor Subtype 4 Couples to the M-Current to Regulate Seizures J. Neurosci., April 2, 2008; 28(14): 3567 - 3576. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. M. Luque and R. D. Kineman Gender-Dependent Role of Endogenous Somatostatin in Regulating Growth Hormone-Axis Function in Mice Endocrinology, December 1, 2007; 148(12): 5998 - 6006. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. Gonzalez-Rey, A. Chorny, R. G Del Moral, N. Varela, and M. Delgado Therapeutic effect of cortistatin on experimental arthritis by downregulating inflammatory and Th1 responses Ann Rheum Dis, May 1, 2007; 66(5): 582 - 588. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. Gonzalez-Rey, A. Chorny, G. Robledo, and M. Delgado Cortistatin, a new antiinflammatory peptide with therapeutic effect on lethal endotoxemia J. Exp. Med., March 20, 2006; 203(3): 563 - 571. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. Gonzalez-Rey, N. Varela, A. F. Sheibanie, A. Chorny, D. Ganea, and M. Delgado Cortistatin, an antiinflammatory peptide with therapeutic action in inflammatory bowel disease. PNAS, March 14, 2006; 103(11): 4228 - 4233. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Genetically Modified Animals in Endocrinology Endocr. Rev., August 1, 2004; 25(4): 673 - 677. [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |
